Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junlong Li

Showing results (41-50 of 149) with videos related to

Pageof 15
Sort By:
Frontiers in Medicine|May 18, 2026
The perspective of manual therapy as a fascia-directed biomechanical intervention in myofascial pain syndromeHaiteng Wang, Peizhen Zhang, Jianwu Wang, et al.
Bone Reports|April 20, 2026
Comparison of KN012, a denosumab biosimilar, versus reference denosumab in Chinese postmenopausal women with osteoporosis: efficacy, safety, and population pharmacokinetics in a 12-month phase III studyXiufen Zhu, Jia Liu, Yanhong Mao, et al.
Biomedical Reports|June 16, 2015
Detection of the SHV genotype polymorphism of the extended-spectrum β-lactamase-producing Gram-negative bacteriumJunlong Li, Xiaoli Ji, Xiaohui Deng, et al.
Biosensors & Bioelectronics|November 7, 2016
A fluorescence biosensor for VEGF detection based on DNA assembly structure switching and isothermal amplificationJunlong Li, Kexin Sun, Zhongping Chen, et al.
Urolithiasis|April 9, 2021
Significance of preoperative systemic immune-inflammation (SII) in predicting postoperative systemic inflammatory response syndrome after percutaneous nephrolithotomyChao Peng, Junlong Li, Gang Xu, et al.
Anti-Cancer Drugs|February 2, 2023
Case report: durable complete response to pembrolizumab plus lenvatinib in a metastatic upper tract urothelial carcinoma patient with high tumor mutational burden and an immune-active tumor microenvironmentJing Jin, Junlong Li, Chao Peng, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|May 16, 2025
Health Poverty Reduction Policies and Effectiveness Evaluation in China Since 2015: A Narrative ReviewJunlong Li, Tiancheng Zhao, Zhiling Liu, et al.
Current Medical Research and Opinion|August 5, 2016
Association between time to progression and subsequent survival inceritinib-treated patients with advanced ALK-positive non-small-cell lung cancerGeoffrey Liu, Jie Zhang, Zheng-Yi Zhou, et al.
Scientific Reports|November 9, 2024
Novel insights of disulfidptosis-mediated immune microenvironment regulation in atherosclerosis based on bioinformatics analysesHuanyi Zhao, Zheng Jin, Junlong Li, et al.
The Journal of Dermatological Treatment|June 14, 2017
Number needed to treat and costs per responder among biologic treatments for moderate-to-severe plaque psoriasis in JapanShinichi Imafuku, Ataru Nakano, Hidetoshi Dakeshita, et al.
Pageof 15

Showing results (41-50 of 149) with videos related to

Sort By:
Pageof 15
Frontiers in Medicine|May 18, 2026
The perspective of manual therapy as a fascia-directed biomechanical intervention in myofascial pain syndromeHaiteng Wang, Peizhen Zhang, Jianwu Wang, et al.
Bone Reports|April 20, 2026
Comparison of KN012, a denosumab biosimilar, versus reference denosumab in Chinese postmenopausal women with osteoporosis: efficacy, safety, and population pharmacokinetics in a 12-month phase III studyXiufen Zhu, Jia Liu, Yanhong Mao, et al.
Biomedical Reports|June 16, 2015
Detection of the SHV genotype polymorphism of the extended-spectrum β-lactamase-producing Gram-negative bacteriumJunlong Li, Xiaoli Ji, Xiaohui Deng, et al.
Biosensors & Bioelectronics|November 7, 2016
A fluorescence biosensor for VEGF detection based on DNA assembly structure switching and isothermal amplificationJunlong Li, Kexin Sun, Zhongping Chen, et al.
Urolithiasis|April 9, 2021
Significance of preoperative systemic immune-inflammation (SII) in predicting postoperative systemic inflammatory response syndrome after percutaneous nephrolithotomyChao Peng, Junlong Li, Gang Xu, et al.
Anti-Cancer Drugs|February 2, 2023
Case report: durable complete response to pembrolizumab plus lenvatinib in a metastatic upper tract urothelial carcinoma patient with high tumor mutational burden and an immune-active tumor microenvironmentJing Jin, Junlong Li, Chao Peng, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|May 16, 2025
Health Poverty Reduction Policies and Effectiveness Evaluation in China Since 2015: A Narrative ReviewJunlong Li, Tiancheng Zhao, Zhiling Liu, et al.
Current Medical Research and Opinion|August 5, 2016
Association between time to progression and subsequent survival inceritinib-treated patients with advanced ALK-positive non-small-cell lung cancerGeoffrey Liu, Jie Zhang, Zheng-Yi Zhou, et al.
Scientific Reports|November 9, 2024
Novel insights of disulfidptosis-mediated immune microenvironment regulation in atherosclerosis based on bioinformatics analysesHuanyi Zhao, Zheng Jin, Junlong Li, et al.
The Journal of Dermatological Treatment|June 14, 2017
Number needed to treat and costs per responder among biologic treatments for moderate-to-severe plaque psoriasis in JapanShinichi Imafuku, Ataru Nakano, Hidetoshi Dakeshita, et al.
Pageof 15